BMJ  2004;329:695-696 (25 September), doi:10.1136/bmj.329.7468.695

Editorial

Treatment for impetigo

Evidence favours topical treatment with mupirocin, fusidic acid

The first 150 words of the full text of this article appear below.

Impetigo is a bacterial skin infection, the fourth most common dermatological skin disorder in children seen in general practice. Most patients are treated by general practitioners. Proper hygiene and adequate treatment supposedly control the infection, but over the past decade the incidence of impetigo has not declined in the Netherlands.1 For the individual patient, impetigo is a minor disease as a cure can be expected within weeks with most treatments. In developed countries, serious complications such as acute glomerulonephritis are rare.2 Nevertheless the impact of an impetigo outbreak can be considerable. The unattractive appearance of the lesions may worry parents, and children are often barred from schools and kindergartens because of fear of spread of the infection. Outbreaks of impetigo caused by multiple resistant staphylococci have been reported.3 4 For the clinician the choice of treatment will be based primarily on effectiveness and side effects and then on costs and convenience . . . [Full text of this article]

Sander Koning, general practitioner

Erasmus MC, University Medical Center Rotterdam, PO Box 1738, Rotterdam 3000 DR, Netherlands (s.koning@erasmusmc.nl)

Johannes C van der Wouden, researcher

Erasmus MC, University Medical Center Rotterdam, PO Box 1738, Rotterdam 3000 DR, Netherlands


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Treatment of impetigo: Paint it blue
Roderic S MacDonald
BMJ 2004 329: 979. [Extract] [Full Text]

Treatment of impetigo: Save mupirocin
Inge Axelsson
BMJ 2004 329: 979. [Extract] [Full Text]

Health needs of Zimbabweans are poorly recognised in UK
Steve Gillam, Raj Khanchandani, and Melusi Ndebele
BMJ 2004 329: 979. [Extract] [Full Text]

This article has been cited by other articles:

  • MacDonald, R. S (2004). Treatment of impetigo: Paint it blue. BMJ 329: 979-979 [Full text]  
  • Axelsson, I. (2004). Treatment of impetigo: Save mupirocin. BMJ 329: 979-979 [Full text]  

Rapid Responses:

Read all Rapid Responses

Paint it blue
Roderic S MacDonald
bmj.com, 4 Oct 2004 [Full text]
Save mupirocin
Inge Axelsson
bmj.com, 11 Oct 2004 [Full text]
Treatment of impetigo for whom?
Malcolm I McDonald, et al.
bmj.com, 18 Oct 2004 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ